Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > WTF Just Happened Yesterday ???
View:
Post by Scorpio2 on Apr 06, 2022 1:03pm

WTF Just Happened Yesterday ???

Weak hands, undecipherable NR and no BTD put the crack in the dyke. Then the opportunistic scam traders recognized the weaker fundamentals of the dyke and rode the wave of water down further. This was an orchestrated flash crash just like in Nov of 2017, which I remember very well.. 

Now we see that they have placed walls (larger sell orders) much lower down. It's like some pharma company (and the trader team acting for them) is saying "we will control the price for the near future and here are a few stop signs to slow things down". All an attempt to harvest more shares to reduce the cost of a future take out/buyout. So as investors we will just have to play the long game a little longer. The data will come, it will improve along with the share price and all of this will be a distant memory in a few months. The next update will have more patients enrolled , more robust data along with more pendings moved to CR. Maybe we will even have a response on the BTD within the next two months as well.

This is where you just have to check the emotions and focus on the end game. Data is going in the right direction. We will get there and we will get some form of a deal whether that's a JV,buyout or licensing arrangement.  If this company didn't have the goods (or a good probability of getting there) these scum traders wouldn't be employing all of these greasy tactics. It's a blood sport so hold strong!!!!
Comment by stocksnbonds458 on Apr 06, 2022 1:13pm
It might not hurt to put an informal shareholders group together, I think that less than one hundred if us own more than 50% of the company. My family now has close to 2 million shares, I know others with more. Might help us down the road if big pharma want to whack us.
Comment by ScienceFirst on Apr 06, 2022 1:31pm
There will be many big pharmas that will all want to jv with us.  So hard for them to think they're all alone, so one of them will have to move faster than the others.   That's why I don't think one big pharma in particular is involved in suppressing the share price.  Any of them could jump in asap, to shift its competitors, as it's a race to market dominance.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250